Citation Impact
Citing Papers
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Inflammation and cancer
2002 StandoutNature
The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies
2002 Standout
NK cells for cancer immunotherapy
2020
On the Use of Herbal Medicines in Management of Inflammatory Bowel Diseases: A Systematic Review of Animal and Human Studies
2008
Nanomaterials for T-cell cancer immunotherapy
2021
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Clinical lessons learned from the first leg of the CAR T cell journey
2019
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
2020
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Toxicity and management in CAR T-cell therapy
2016
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
2000
Macrophages in immunoregulation and therapeutics
2023 Standout
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Ursolic acid: An anti‐ and pro‐inflammatory triterpenoid
2008 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?
2014
Programming CAR-T cells to kill cancer
2018
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
2021
Implications of Human Macrophage Metalloelastase and Vascular Endothelial Growth Factor Gene Expression in Angiogenesis of Hepatocellular Carcinoma
2000
Curcumin: The story so far
2005 Standout
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis
2009
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Inflammation and cancer: back to Virchow?
2001 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Making CAR T Cells a Solid Option for Solid Tumors
2018
Systematic Review of Complementary and Alternative Medicine Treatments in Inflammatory Bowel Diseases
2014
Angiogenesis as a biomarker and target in cancer chemoprevention
2001
Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML
2017
Angiotensin-I-Converting Enzyme Inhibitors May Be an Alternative Anti-Angiogenic Strategy in the Treatment of Liver Fibrosis and Hepatocellular Carcinoma
2002
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
De novo design of tyrosine and serine kinase-driven protein switches
2021 StandoutNobel
Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: A meta-analysis
2013
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
The role of IL-6 and STAT3 in inflammation and cancer
2005 Standout
Altered expression of vascular endothelial growth factor, fibroblast growth factor‐2 and endostatin in patients with hepatocellular carcinoma
2005
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
2022 StandoutNobel
The Fibroblast Growth Factor signaling pathway
2015 Standout
Systematic review: the efficacy of herbal therapy in inflammatory bowel disease
2013
Myeloid cell and cytokine interactions with chimeric antigen receptor-T-cell therapy: implication for future therapies
2019
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
2018
Chimeric Antigen Receptor Therapy
2018 Standout
Tumor Antigen Escape from CAR T-cell Therapy
2018
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
2019
CAR T Cell Therapy: A Game Changer in Cancer Treatment
2016
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Genepolide, a Sesterpene γ-Lactone with a Novel Carbon Skeleton from Mountain Wormwood (Artemisia umbelliformis)
2008
Nonalcoholic Fatty Liver Disease
2015 Standout
Works of Bilal Omer being referenced
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
2017
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
2019
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
2017
Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: A double-blind placebo-controlled study
2007
Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn’s disease – A controlled clinical trial
2009
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1
2017
Chronic Viral Hepatitis Induced by Hepatitis C But Not Hepatitis B Virus Infection Correlates With Increased Liver Angiogenesis
1997
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application
2015
Wormwood (Artemisia absinthium) for Poorly Responsive Early-Stage IgA Nephropathy: A Pilot Uncontrolled Trial
2010
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells
2017